Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Immediacy Index: 0.927
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 631
  • Print this page
  • Email this page
This article has been cited by
1Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis
María José Germanó,Juan Pablo Mackern-Oberti,Jessica Gardone Vitório,Mariana Costa Duarte,Daniel Carvalho Pimenta,Maria Victoria Sanchez,Flavia Alejandra Bruna,Esteban Sebastián Lozano,Ana Paula Fernandes,Diego Esteban Cargnelutti
Frontiers in Immunology.2022;13()
[DOI]
2Evaluation of different total Leishmania amazonensis antigens for the development of a first-generation vaccine formulated with a Toll-like receptor-3 agonist to prevent cutaneous leishmaniasis
María José Germanó,Esteban Sebastián Lozano,María Victoria Sanchez,Flavia Alejandra Bruna,María Fernanda García-Bustos,Arianna Lourdes Sosa Lochedino,María Cristina Salomón,Ana Paula Fernandes,Juan Pablo Mackern-Oberti,Diego Esteban Cargnelutti
Memórias do Instituto Oswaldo Cruz.2020;115()
[DOI]
3Therapeutic effect of Prosopis strombulifera (LAM) BENTH aqueous extract on a murine model of cutaneous leishmaniasis
Esteban Sebastián Lozano,María José Germanó,Mariana Elizabeth Troncoso,María Fernanda García Bustos,Carlos Gamarra Luques,Diego Esteban Cargnelutti
Journal of Traditional and Complementary Medicine.2022;12(3)281
[DOI]
4Estudio clínico y epidemiológico de Leishmaniasis Cutánea en un Hospital Nivel II Del Perú
Charles Frank Saldaña-Chafloque,Miguel Ivan Saldaña-Alfaro,Rosita Isabel Saldaña-Chafloque,Mercedes Acosta-Román
Llamkasun.2021;2(4)23
[DOI]